Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who’s counting down for the nothing burger on September 30?
It’s a broken record false narrative. DCVax-L can get MAA approval & NICE appraisal with or without Flashworks. Stop pushing the flashworks narrative!
EXACTLY!
I’m not buying the delay due to Flashworks integration. The idea you’re suggesting is ridiculous. It’s like a car company saying they can’t launch a car because they’re developing a better engine, and until they finish building the new engine, they can’t sell the car with the current one. In fact, DCVax-L can be appraised with or without Flashworks!
How come this management can't find the time to do the submittal. What the f are they waiting for? There's no way they are too busy or can't find a time for this. It's BS!
I wonder how many outstanding shares were added today. Management probably took advantage of the spike last Friday.
You mean you regretted not selling at $0.38 and to buy them later this week.
If MHRA needs any additional information from the management then yes chances of approval to be in 2025 is like 100%.
That’s why I asked her to change the question. lol
It should be: How many believe that this will happen this year?
Unfortunately, these authors aren’t the one to decide that it’s the MHRA.
Again, without L, she won’t get a partner. If L is a bust, she will be forced to sell L & D at a bargain price.
I highly doubt that’s the case. If this investor/s really exist, the past two years of accumulation should be enough. Let’s just face the fact that we don’t have whales in this investment. Why? Who knows, it defies the logic and science. A potential cancer vaccine to come toe to toe to the standard of care and nobody in the 1% wealthiest percent notice it or care to put a bet into this and only the small time retail know it’s potential value? I find it hard to believe.
How can they restart D with this broke company? They need L success to do that.
If there’s no spoofing, then there’s no case, and the MTD will be approved. If there is a settlement, then spoofing exists. LP would be stupid to accept cash without stopping the spoofing if a settlement occurs.
Exactly! The fact that spoofing is still happening means that there hasn’t been a deal or settlement yet, or maybe there won’t be any at all. LP would be stupid to accept a cash settlement without putting an end to the spoofing. Judge is probably stalling the decision. I don’t buy the idea that KG or HFs can’t influence these judges.
When is the END game? 2030?
5m shares trading at .33 is large investor/s?
5m shares trading at .33 is a large investors to you?smfh
Partnering with Oncovir is not gonna help the share price. Even they announced it. two very small companies one is private and one is public who do you think will finance between the two? Exactly! US!
A rumor says the judge is waiting for MHRA approval, which is why they are in a quiet period as well.
Ocrevus SC (subcutaneous) submitted its Marketing Authorization Application (MAA) to the UK Medicines and Healthcare products Regulatory Agency (MHRA) on February 28, 2023. The MHRA granted approval for the subcutaneous formulation of Ocrevus on July 18, 2023.
Which is blazing fast. What about NWBO? You can’t compare the approval durations, as some drugs are more complicated than others. Maybe NWBO will set a Guinness World Record again for the time it takes to receive an approval decision.:P
"The duration of the decision doesn't really determine whether it's approved or denied. I've seen rejections happen not very quickly; in fact, it took several months to receive a rejection, while approvals can occur very quickly as well.
"If the claim about the 210-day process plus 100 days behind target is accurate, then a full year should be sufficient to reach a decision on the DCVAX-L drug. There should be no reason for the decision not to be made this year. Whether it is approved or denied, it must happen this year.
We all have different situations in life. Actually, I'm at a point where I need the money that I didn't need before; the money I was willing to lose before but not now (tough times). So, I'm going to have to take whatever gains come my way.
Oh, I will make sure to reap the benefits when MAA approval comes through. I’m ready to dispose of 80% of my position at around $2-$4 and leave just 10-40k shares. A gain is a gain. I don’t care if I miss out on the ‘future intrinsic value.’ I’m not going to risk losing potential gains out of greed for generating generational wealth.
From +7% to -3% 😂
A good speculation maybe it's not a news.
Why don’t you ask the CEO of Merck? Maybe he’s not seeing the value in NWBO, because I don’t see the pile of cash on the table that any of you have suggested.
What I regret is not selling this when it was $1 in Q4 last year. I could have tripled my position if I had done that and followed my gut feeling.
You guys keep talking in circles, like a never-ending loop.
Salivating? How long has it been since Duffy entered and left NWBO? Is there any progress on the BO or partnership? Get back to me if you have concrete information about any offers between the two. Stop speculating; it's nonsense.
Most people will be happy with a decent amount of gains. When I sold BTC at $15k, having bought it at $3k, did I regret selling it? No. Yes, it would have been nice to hold it until today, but a gain is a gain. You don’t regret something with a positive outcome; you only regret something with a negative outcome.
I'll be happy with a 10 bagger from $.35 to $4.00.
I understand that they're waiting for UK approval to increase the chances of FDA approval. However, even once that happens, they'll need to make another submission, which will likely take months. I doubt that the submission made to the MHRA will be suitable for all regulators. So, 2025 for FDA approval seems like an overly optimistic speculation.
Why do you guys even talk about this as if Merck announced a buyout? Debating something that isn't even happening...LOL. Are you guys that bored and have nothing better to do? All these ridiculous speculations.
Management doesn’t seem to understand the concept of multitasking. The only thing they manage to multitask with is patent applications.
EXACTLY
FDA will approve DCVax in the US in 2025.
How can you be bullish on something that hasn't even been submitted for approval? That's definitely a pure speculation, imo.
If they submitted this year then that's a different story.
if you can show us a proof of a stock parallel to NWBO that hit intrinsic value after MHRA approval not FDA approval.
No doubt it will definitely hit $1-3 but $4 and higher I don’t know about it. Look at NVCR with an approved device and it’s not even 2B MC.